Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-FR
Language French French
Date Updated 2022-12-09 2022-09-02
Drug Identification Number 00587737 00587737
Brand name HUMULIN N HUMULIN N
Common or Proper name insulin isophane, human biosynthetic (rDNA origin) insulin isophane, human biosynthetic (rDNA origin)
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients INSULIN NPH HUMAN DNA ORIGIN INSULIN NPH HUMAN DNA ORIGIN
Strength(s) 100UNIT 100UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size Vial HI0313, 3 mL, 100 units/mL Vial HI0313, 3 mL, 100 units/mL
ATC code A10AC A10AC
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-11-16 2022-11-16
Actual discontinuation date 2022-12-07
Remaining supply date 2022-11-10 2022-11-16
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Humulin N 3 mL vial presentation shares a DIN with the 10 mL vial presentation (00587737). Humulin N 10 mL vial presentation will continue to be available. For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). Humulin N 3 mL vial presentation shares a DIN with the 10 mL vial presentation (00587737). Humulin N 10 mL vial presentation will continue to be available. For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments